ATP13A2 and Parkinson disease: ATP13A2, also known as PARK9, is a P5-type lysosomal ATPase with mutations that have been linked to Kufor-Rakeb syndrome, an autosomal recessive, juvenile-onset form of PD characterized by parkinsonism [36].